Design of an Injectable Polypeptide Hydrogel Depot Containing the Immune Checkpoint Blocker Anti-PD-L1 and Doxorubicin to Enhance Antitumor Combination Therapy
Macromolecular bioscience, 2021-06, Vol.21 (6), p.e2100049 [Peer Reviewed Journal]2021 Wiley-VCH GmbH. ;EISSN: 1616-5195 ;DOI: 10.1002/mabi.202100049 ;PMID: 33871152
Digital Resources/Online E-Resources